Prevalence of Chlamydia pneumoniae specific antibodies in different clinical situations and healthy subjects in Izmir, Turkey

Simple item page
dc.contributor.authorGencay M.
dc.contributor.authorDereli D.
dc.contributor.authorErtem E.
dc.contributor.authorSerter D.
dc.contributor.authorPuolakkainen M.
dc.contributor.authorSaikku P.
dc.contributor.authorBoydak B.
dc.contributor.authorDereli S.
dc.contributor.authorÖzbakkaloglu B.
dc.contributor.authorYorgancioglu A.
dc.contributor.authorTez E.
dc.date.accessioned2024-07-22T08:25:52Z
dc.date.available2024-07-22T08:25:52Z
dc.date.issued1998
dc.description.abstractSerological markers for Chlamydia pneumoniae were investigated by using the microimmunofluorescence (MIF) test in various age and patient groups in a specific area in Turkey. IgG seropositivity to C. pneumoniae was 64.3% and 18.7% in healthy adults and children, respectively. The highest positivity rate (77%) was in the 15-19 age group. Among the groups investigated, serological findings revealed a possible etiological association between C. pneumoniae and the clinical condition in the groups with acute myocardial infarction, atypical pneumoniae and chronic obstructive pulmonary disease.
dc.identifier.DOI-ID10.1023/A:1007404315879
dc.identifier.issn03932990
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/20647
dc.language.isoEnglish
dc.subjectAdolescent
dc.subjectAdult
dc.subjectAged
dc.subjectAged, 80 and over
dc.subjectAntibodies, Bacterial
dc.subjectChild
dc.subjectChild, Preschool
dc.subjectChlamydia Infections
dc.subjectChlamydophila pneumoniae
dc.subjectFemale
dc.subjectFluorescent Antibody Technique
dc.subjectHumans
dc.subjectImmunoglobulin A
dc.subjectImmunoglobulin G
dc.subjectImmunoglobulin M
dc.subjectInfant
dc.subjectLung Diseases, Obstructive
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectMyocardial Infarction
dc.subjectPneumonia
dc.subjectPrevalence
dc.subjectRisk Factors
dc.subjectSeroepidemiologic Studies
dc.subjectTurkey
dc.subjectimmunoglobulin A antibody
dc.subjectimmunoglobulin G antibody
dc.subjectimmunoglobulin M antibody
dc.subjectmarker
dc.subjectacute heart infarction
dc.subjectadolescent
dc.subjectadult
dc.subjectage
dc.subjectaged
dc.subjectarticle
dc.subjectchild
dc.subjectChlamydophila pneumoniae
dc.subjectchronic obstructive lung disease
dc.subjectclinical trial
dc.subjectcontrolled study
dc.subjectfemale
dc.subjecthuman
dc.subjecthuman experiment
dc.subjecthuman tissue
dc.subjectimmunofluorescence test
dc.subjectinfant
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectnormal human
dc.subjectrisk factor
dc.subjectseroprevalence
dc.subjectTurkey (republic)
dc.titlePrevalence of Chlamydia pneumoniae specific antibodies in different clinical situations and healthy subjects in Izmir, Turkey
dc.typeArticle

Files

Collections

Scopus Koleksiyonu